Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

MCC Update 12-10-13

AHCMCC2 - Image - 560x80 - Update banner

Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman,, by noon on Friday for publication the following Tuesday.

December 10, 2013

In This Issue

Cancer Center Seminar 


Clinical Trials

Professional Education


Funding Opportunities

Cancer Center Seminar

No seminar due to ASH meeting.

A peek at next week's seminar:

PLEASE NOTE: This seminar will be simulcast to 450 MCRB. Shuttles to CCRB may be boarded in front of Variety Club Heart Clinic on E. River Parkway. See website for details on pick-up time.

Tuesday, December 17, 2013, 12-1 p.m., 450 MCRB
Noncoding RNAs are novel regulators in ovarian cancer
Lynne T. Bemis, Ph.D., Chair, Biomedical Sciences, Program Director, Native American Faculty Development Program, University of Minnesota Medical School-Duluth

Hosts: Jim McCarthy, Ph.D., and Kalpna Gupta, Ph.D.

Visit the calendar for a schedule of seminars.

Back to top


Julie Ross, Ph.D., Prevention and Etiology Program, in a collaborative study with Todd Druley, M.D., Ph.D., a Washington University pediatric oncologist and geneticist, published a paper in Leukemia showing that infants with leukemia have a particular causing variants in their healthy  DNA that may increase their susceptibility to developing leukemia. These findings could lead to the discovery of the causes of infant leukemia and help develop treatment strategies.

Development officer joins U of M Foundation Masonic Cancer Center team
Chris Cheney will be joining the University of Minnesota Foundation as development officer for the Masonic Cancer Center Wednesday, December 11. Chris worked as a donor engagement officer at the National MS Society and as the finance and development/outreach manager for Bolder Options. Prior to these experiences, he was a financial planner/business owner. Chris holds a Bachelor of Arts in Psychology from St. Olaf College and a Master of Education from the University of Minnesota. Chris’s efforts will focus on major gifts across cancer as well as developing strategies for corporate, foundation and Gopher athletic engagement.

Back to top

Clinical Trials

The following clinical trials conducted by Masonic Cancer Center members were recently opened:

COG ADVL 1217: A Phase 1 Study of MK-1775 (IND# 116495) Concurrent with Local Radiation Therapy for the Treatment of Newly Diagnosed Children with Diffuse Intrinsic Pontine Gliomas
PI: Greengard, Emily

HM2013-16 A Phase 1 Study of DT2219ARL: A Bispecific SIngle Chain Immunotoxin for the Treatment of CD19+, CD22+ B-lineage Leukemia or Lymphoma
PI: Bachanova, Veronika

COG ADVL1213 - A Phase 1 Study of the TEM-1 Antibody, MORAb-004 (IND#103821), in Children with Recurrent or Refractory Solid Tumors
PI: Greengard, Emily

For more information on clinical trials contact Marva Bohen, R.N., B.S.N. (,  612-624-2620).

Back to top

Professional Education

December 11, 2013: Breast Cancer Journal Club
1-2 p.m., 3-224 CCRB
Polly Chuntova, Schwertfeger lab, will discuss "A novel model of dormancy for bone metastatic breast cancer cells," by Marlow R et al. in Cancer Res. 2013;73(23):6886-99.

December 11, 2013: Cancer Biology Research Club
12-1 p.m., 6-101 NHH
Leveraging APOBEC3B for cancer therapy
Brandon Leonard, Cancer Biology Training Grant predoctoral fellow, Harris lab

View the schedule on the website.

December 12, 2013: Sixth Annual David A. Rothenberger Lecture
4 p.m., Mayo Auditorium
Will physicians lead us through health care challenges?
Bill George, former chair and chief executive of Medtronic; professor of management practice at Harvard Business School; board member: Mayo Clinic, Exxon Mobil and Goldman Sachs; former chair of the board of Allina Health System and Abbott Northwestern Hospital

January 22, 2014: Writing Winning Grants
8:30 a.m.-4 p.m., McNamara Alumni Center
Want to write successful health research grants? Then don't miss "Write Winning Grant Proposals," a day-long seminar that will comprehensively address practical and conceptual aspects important to the proposal-writing process.

Registration fee: $75

The seminar is hosted by the Clinical and Translational Science Institute, Center for Health Equity and Minnesota Center for Cancer Collaborations. Register for the event.

Visit the Education and Training Opportunities web page for more conference and special lecture listings.

Back to top


May 17, 2014: Save the Date: Cancer Survivorship Series
Click here to be added to the Cancer Survivor Program mailing list to receive registration information for this conference when it is available closer to the date.

Visit the Community Events and Outreach page for more information.

Back to top

Funding Opportunities

News & Notices:

Deadline extended to 12/30/13 for KWRIS (see Funding Opportunites on the website for the pdf with application information)
In an effort to maximize the applicant pool, the deadline for submitting a proposal to the Karen Wyckoff Rein In Sarcoma Foundation is being extended to Monday, December 30, 2014. Previous awardees are encouraged to apply.

Funding Opportunities:

Funding for High-Impact Pediatric Cancer Research
Sponsor: Solving Kids’ Cancer Foundation
Clinical Idea of Intent Deadline: open-ended (through 2014 calendar year)
Proposal Deadline: notification to fully submit will occur 5 weeks after intent submisison
Amount: $50,000 - $600,000 depending on scope

BRCA Research Grants
Sponsor: The Basser Research Center for BRCA at Penn Medicine's Abramson Cancer Center
Mandatory Letter of Intent Deadline: January 6, 2014
Proposal Deadline: February 14, 2014

  • Basser Team Science Award

$1,000,000 over 2 years

  • Basser Innovation Award

$100,000 for 1 year

2014 Driven to Discover Community Health Research Grants Program
Sponsor: UMN Clinical and Translational Science Institute (CTSI)
Optional Letter of Intent Deadline: January 2, 2014
Full Application Deadline: January 31, 2014
Amount: Up to $30,000
Note: Studies funded through this mechanism must enroll and collect data from subjects at the 2014 Minnesota State Fair using the new Driven to Discover research building. This dedicated research facility offers university and community researchers access to approximately 1.7 million potential participants each year, and will be a unique resource for carrying out population-based research.

Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.

Back to top

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on December 16, 2013